How long can a person live with early-stage cirrhosis?

Jun 07, 2022 Source: Cainiu Health
Dr. Jin Zhongkui
Introduction
In early-stage cirrhosis, if the disease does not progress, life expectancy is generally not significantly affected, and the survival rate can remain around 80–86%. However, without treatment, early-stage cirrhosis may progress to decompensated cirrhosis, which occurs in approximately 5% of cases. Therefore, early-stage cirrhosis represents the most critical window for intervention and treatment.

  Frequent smoking, alcohol consumption, and staying up late can increase the liver’s workload, leading to extensive degeneration and necrosis of hepatocytes, potentially resulting in cirrhosis. Since hepatic dysfunction in cirrhosis is often irreversible, it may adversely affect life expectancy. Depending on disease severity, cirrhosis is classified into three stages: early, intermediate, and advanced. So, how long can a person live with early-stage cirrhosis?

  Life Expectancy with Early-Stage Cirrhosis

  In early-stage cirrhosis, if the disease remains stable without progression, life expectancy is generally not significantly affected, with a 5-year survival rate of approximately 80–86%. However, if left untreated, early-stage cirrhosis may progress to decompensated cirrhosis, which occurs in roughly 5% of cases. Therefore, early-stage cirrhosis represents the most critical window for intervention, and treatment strategies should be tailored to the underlying cause.

  Prevention of cirrhosis should target its root causes. In cases of congenital metabolic disorders, prevention is not feasible; instead, emphasis should be placed on eugenics and proper upbringing. For cirrhosis caused by viral hepatitis, prevention primarily involves maximal suppression of viral replication to reduce or even reverse fibrotic progression. Specifically, cirrhosis induced by hepatitis B virus (HBV) requires antiviral therapy. However, some HBV-infected individuals—particularly those infected perinatally—may remain in an immune-tolerant phase: although viral load is high and hepatitis B surface antigen (HBsAg) titers are elevated, liver function tests remain completely normal. In such cases, aggressive antiviral therapy is generally not recommended.

  Patients are advised to maintain healthy dietary and lifestyle habits and seek prompt medical evaluation upon noticing any symptoms. We hope this information has been helpful.